Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Sell
9
HEPA Quote, Financials, Valuation and Earnings
Last price:
$0.80
Seasonality move
:
350.05%
Day range:
$0.72 - $0.83
52-week range:
$0.67 - $145.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.60x
Volume:
2.9M
Avg. volume:
1.1M
1-year change:
-99.31%
Market cap:
$863.9K
Revenue:
--
EPS (TTM):
-$4.38
Earnings Data
Next earnings date for HEPA
May 21
2025
Most recent earnings per share
-$36.00
Missed by $36.00
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HEPA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 | -- | -- | -$36.00 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$34.00 | -- | -- |
| 05/21/2024 | Q1 | -- | -- | -$28.00 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$121.00 | -$131.50 | $10.50 |
| 11/20/2023 | Q3 | -- | -- | -$137.00 | -$156.00 | $19.00 |
| 08/14/2023 | Q2 | -- | -- | -$184.00 | -$166.17 | -$17.83 |
| 05/12/2023 | Q1 | -- | -- | -$174.00 | -$180.00 | $6.00 |
| 12/31/2022 | Q4 | -- | -- | -$131.00 | -$130.00 | -$1.00 |
| 11/14/2022 | Q3 | -- | -- | -$112.00 | -$170.00 | $58.00 |
| 08/15/2022 | Q2 | -- | -- | -$261.00 | -$120.00 | -$141.00 |
| 05/16/2022 | Q1 | -- | -- | -$91.00 | -$130.00 | $39.00 |
| 12/31/2021 | Q4 | -- | -- | -$130.00 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$120.00 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$100.00 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$120.00 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$154.74 | -- | -- |
| 11/16/2020 | Q3 | -- | -- | -$690.00 | -- | -- |
| 08/12/2020 | Q2 | -- | -- | -$580.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$970.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$588.08 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$530.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$1,863.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$6,761.05 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$9,361.67 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$38,467.24 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$26,507.07 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$17,817.80 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$18.65 | -$44.80 | $26.15 |
| 09/30/2017 | Q3 | -- | -- | -$41,540.83 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$4,800.41 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$67,421.47 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$40,227.56 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$48,655.53 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$91,338.05 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$81,614.44 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$63,134.04 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$124,216.46 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$137,825.67 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$189,687.85 | -- | -- |
Hepion Pharmaceuticals Earnings Questions
-
How Much did Hepion Pharmaceuticals Generate in Revenue Last Quarter?
Hepion Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Hepion Pharmaceuticals Beat Earnings Last Quarter?
Hepion Pharmaceuticals announced earnings per share of -$36.00 which represents a miss of analyst forecast a -- per share.
-
Is Hepion Pharmaceuticals Profitable?
Hepion Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Hepion Pharmaceuticals EPS Next Year?
Hepion Pharmaceuticals's earnings are forecast to decrease from -$12.32 per share to -$11.43 per share next year representing a decrease of -7.22%.
-
When is Hepion Pharmaceuticals's Earnings Date?
Hepion Pharmaceuticals's next earnings date is May 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
